Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial

BACKGROUND: Treatment for major depressive disorder (MDD) is imprecise and often involves trial-and-error to determine the most effective approach. To facilitate optimal treatment selection and inform timely adjustment, the current study investigated whether neurocognitive variables could predict an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychol Med
Main Authors: Ang, Yuen-Siang, Bruder, Gerard E., Keilp, John G., Rutherford, Ashleigh, Alschuler, Daniel M., Pechtel, Pia, Webb, Christian A., Carmody, Thomas, Fava, Maurizio, Cusin, Cristina, McGrath, Patrick J., Weissman, Myrna, Parsey, Ramin, Oquendo, Maria A., McInnis, Melvin G., Cooper, Crystal M., Deldin, Patricia, Trivedi, Madhukar H., Pizzagalli, Diego A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613805/
https://ncbi.nlm.nih.gov/pubmed/33213541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0033291720004286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados